Manchester is one of nine leading universities which will benefit from a record £35 million funding injection from the British Heart Foundation (BHF) to help strengthen world-leading cardiovascular disease research in the UK. The funding comes from the highly competitive Research Excellence Awards funding scheme 

Manchester has been awarded £4 million from the BHF, with the University pledging an additional £4 million in match-funding, providing a total of £8 million to fund world-class cardiovascular and stroke research over the next five years. The Research Excellence Award, led by Professors Bernard Keavney and Maciej Tomaszewski, will support 5 distinct but collaborative themes, which includes a theme focusing on how inflammation drives cardiovascular and stroke disease. The inflammation theme, which is co-led by Professors Craig Smith and Maya Buch, and includes Professors Stuart Allan, Dave Brough and Adam Greenstein from the Geoffrey Jefferson Brain Research Centre, will further our research into how inflammation in common conditions such as arthritis or infections affects the occurrence, progression and outcomes of cardiovascular and stroke disease. The funding will be critical in expanding our existing translational programme of research towards benefits for patients by identifying targets for treatments, developing disease biomarkers and early-stage trials of new therapies.

Related